ResMed Inc. (RMD) Gains Analyst Confidence as Price Targets Rise on Strong Earnings
ResMed Inc. (NYSE:RMD) is one of the best medical technology stocks to invest in. On January 30, KeyBanc Capital Markets lifted its price target on ResMed Inc.
Resmed Inc (RMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 400,000 | $96,348,000 | -43% | 6.34% | |
| 2. | Renaissance Technologies Jim Simons | 304,480 | $73,340,098 | +425% | 0.11% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 273,609 | $65,904,200 | +174% | 0.04% |
| 4. | AQR Capital Management Cliff Asness | 255,884 | $61,634,645 | +16% | 0.03% |
| 5. | Ilex Capital Partners Jonas Diedrich And David Sutton | 246,006 | $59,255,465 | +165% | 1.67% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $69.13 | 2,487 | $171,926.31 | 19,216 | 2016-08-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $273.78 | 4,991 | $1,366,436.48 | 466,223 | 2026-02-09 | Filing | |
| $251.31 | 2,000 | $502,620.00 | 64,773 | 2026-02-04 | Filing | |
| $260.00 | 50 | $13,000.00 | 9,691 | 2026-02-04 | Filing | |
| $257.03 | 1,000 | $257,030.00 | 85,495 | 2026-02-02 | Filing | |
| $248.83 | 2,000 | $497,660.00 | 66,773 | 2026-01-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,882,403 | $4,548,204,411 | 0.07% | |
| 2. | 12,348,652 | $2,974,419,664 | 0.05% | |
| 3. | 6,625,408 | $1,595,862,025 | 0.05% | |
| 4. | 4,890,654 | $1,178,011,765 | 0.21% | |
| 5. | 4,302,906 | $1,032,876,781 | 0.06% |
News See All
10 Best Medical Technology Stocks to Invest In
Medical technology, or MedTech, companies ensure that the broader healthcare industry has the tools needed to diagnose, treat, monitor, or prevent medical conditions.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on RMD.
ResMed Inc. (NYSE:RMD) Q2 2026 Earnings Call Transcript
Operator: Greetings, and welcome to the ResMed Second Quarter Fiscal Year 2026 Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded.
ResMed Inc. (NYSE:RMD) Q1 2026 Earnings Call Transcript
Operator: Hello, and welcome to the Q1 Fiscal Year 2026 ResMed Earnings Conference Call. My name is Kevin. I'll be your operator for today's call.
ResMed Inc. (RMD): A Bull Case Theory
We came across a bullish thesis on ResMed Inc. on CompoundingLab’s Substack. In this article, we will summarize the bulls’ thesis on RMD.
ResMed Inc. (RMD) Launches Global Sleep Institute at World Sleep Congress
ResMed Inc. (NYSE:RMD) is a leading health technology company focused on sleep, breathing, and home care solutions.
7 Hot Healthcare Stocks to Buy Right Now
The majority of Americans have experienced the annoyance of having their health insurance rejected, frequently without any recourse after contacting carriers by email and phone. Dr.
ResMed Inc. (NYSE:RMD) Q4 2025 Earnings Call Transcript
Operator: Hello, and welcome to the Q4 Fiscal Year 2025 ResMed Earnings Conference Call. My name is Kevin, and I'll be your operator for today's call.
Jim Cramer Says The Day "Everything's A Lot More Expensive" Is Coming & Discusses These 10 Stocks
"I've worked for Time for a while . . very few people actually do David anything that's contemporaneous, so to speak, so you're looking at something . .
Hedge Fund Resource Center Billionaire Hedge Funds
